SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.060
-0.010 (-0.93%)
Sep 11, 2026, 5:30 PM CET
SHL Telemedicine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 62.1 | 58.69 | 56.78 | 57.08 | 59 | 49.58 | |
Revenue Growth | 9.27% | 3.37% | -0.52% | -3.26% | 18.99% | 23.45% |
Cost of Revenue | 33.58 | 31.12 | 30.99 | 31.81 | 31.81 | 24.99 |
Gross Profit | 28.52 | 27.57 | 25.79 | 25.26 | 27.19 | 24.59 |
Selling, General & Admin | 27.67 | 27.4 | 27.5 | 26.81 | 28.15 | 21.56 |
Research & Development | 4.04 | 4.68 | 5.36 | 5.26 | 3.79 | 2.99 |
Other Operating Expenses | 1.87 | 1.27 | 1.6 | 0.96 | 0.42 | -0.16 |
Operating Expenses | 33.58 | 33.35 | 34.46 | 33.03 | 32.36 | 24.38 |
Operating Income | -5.06 | -5.78 | -8.67 | -7.77 | -5.17 | 0.21 |
Interest Expense | -1.19 | -0.97 | -1.12 | -1.3 | -1.03 | -0.53 |
Interest & Investment Income | 0.45 | 0.36 | 0.72 | 1.06 | 0.43 | 0.38 |
Currency Exchange Gain (Loss) | -0.41 | -0.41 | 0.16 | 0.99 | 0.61 | -1.59 |
Other Non Operating Income (Expenses) | -0.21 | -0.21 | -0.34 | 1.44 | 0.06 | -0.99 |
EBT Excluding Unusual Items | -6.41 | -7 | -9.25 | -5.58 | -5.1 | -2.52 |
Merger & Restructuring Charges | -1.73 | -1.73 | -1.75 | -1.24 | - | -0.59 |
Impairment of Goodwill | - | - | -13.45 | - | - | - |
Gain (Loss) on Sale of Investments | 0.1 | 0.1 | 0.56 | 0.85 | -0.77 | -0.11 |
Asset Writedown | -5.86 | -5.86 | -2.93 | - | - | -0.12 |
Other Unusual Items | - | - | - | - | 7.18 | -10.13 |
Pretax Income | -13.9 | -14.49 | -26.81 | -5.96 | 1.31 | -13.47 |
Income Tax Expense | 1.07 | 0.89 | 0.94 | 0.89 | 1.1 | 0.46 |
Earnings From Continuing Operations | -14.97 | -15.38 | -27.75 | -6.86 | 0.22 | -13.92 |
Minority Interest in Earnings | - | - | -0.34 | -0.2 | -0.29 | -0.19 |
Net Income | -14.97 | -15.38 | -28.1 | -7.06 | -0.08 | -14.11 |
Net Income to Common | -14.97 | -15.38 | -28.1 | -7.06 | -0.08 | -14.11 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 31 | 21 | 16 | 16 | 15 | 14 |
Shares Outstanding (Diluted) | 31 | 21 | 16 | 16 | 15 | 14 |
Shares Change | 94.25% | 30.75% | 0.59% | 7.22% | 7.71% | 34.33% |
EPS (Basic) | -0.48 | -0.72 | -1.71 | -0.43 | -0.01 | -1.00 |
EPS (Diluted) | -0.48 | -0.72 | -1.71 | -0.54 | -0.49 | -1.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.48 | -3.32 | -1.32 | -2.79 | -1.73 | -0.44 |
Free Cash Flow Per Share | -0.08 | -0.15 | -0.08 | -0.17 | -0.11 | -0.03 |
Gross Margin | 45.93% | 46.98% | 45.43% | 44.26% | 46.09% | 49.60% |
Operating Margin | -8.14% | -9.84% | -15.26% | -13.61% | -8.76% | 0.43% |
Profit Margin | -24.11% | -26.20% | -49.48% | -12.36% | -0.13% | -28.46% |
Free Cash Flow Margin | -3.99% | -5.66% | -2.33% | -4.88% | -2.94% | -0.89% |
EBITDA | -2.34 | -2.77 | -6.24 | -5.4 | -2.43 | 4.35 |
EBITDA Margin | -3.77% | -4.72% | -10.99% | -9.46% | -4.12% | 8.77% |
D&A For EBITDA | 2.72 | 3.01 | 2.43 | 2.37 | 2.74 | 4.14 |
EBIT | -5.06 | -5.78 | -8.67 | -7.77 | -5.17 | 0.21 |
EBIT Margin | -8.14% | -9.84% | -15.26% | -13.61% | -8.76% | 0.43% |
Effective Tax Rate | - | - | - | - | 83.61% | - |